Crossref

1. Establishing ultrasound based transient elastography cutoffs for different stages of hepatic fibrosis and cirrhosis in Egyptian chronic hepatitis C patients

- Aisha Elsharkawy

- Mohamed Alboraie

- Rabab Fouad

- Noha Asem

- Mahmoud Abdo

- Hesham Elmakhzangy

- Mai Mehrez

- Hany Khattab

- Gamal Esmat

2. CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases

- Lucie Coppin

- Kanza Benomar

- François Corfiotti

- Stéphane Cattan

- Florence Renaud

- Camille Lapere

- Emmanuelle Leteurtre

- Marie-Christine Vantyghem

- Stéphanie Truant

- Pascal Pigny

3. Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C

- Ahmed Cordie

- Ahmed Salama

- Marwa El‐Sharkawy

- Saeed M. El‐Nahaas

- Marwa Khairy

- Aisha Elsharkawy

- Mohamed Hassany

- Gamal Esmat

4. Value of Egy‐Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase‐to‐platelet ratio index, FIB‐4 and Forns' index in chronic hepatitis C virus

- Mohamed Alboraie

- Marwa Khairy

- Marwa Elsharkawy

- Noha Asem

- Aisha Elsharkawy

- Gamal Esmat

5. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents

- Saeed M. El-Nahaas

- Normeen Hany Rady

- Shimaa Malek

- Khaled Serag